AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / BLANK CHECKS
Drugs Made In America Acquisition II Corp. Ordinary Shares
XNAS · usd
SIC 6770 · BLANK CHECKS
FIGI AK-B1961DE845
10.19▲ 0.00 (0.00%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
—
Trailing P/E
—
Price / Sales
—
EV / Revenue
—
EV / EBITDA
—
Financial Highlights
Revenue (TTM)
—
Net Income (TTM)
—
EBITDA
—
Diluted EPS (TTM)
—
EBITDA Margin
—
Net Debt
—
Trading Information
Previous Close
10.19
Day's Range
10.19 – 10.19
52-Week Range
9.86 – 10.33
Volume
277
Avg Volume
186.7K
Share Statistics
Shares Outstanding
Employees
2
Exchange
XNAS
Listed
2025-12-03
Share count as of August 14, 2026

Drugs Made In America Acquisition II Corp. Ordinary Shares (DMII) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about Drugs Made In America Acquisition II Corp. Ordinary Shares (DMII)
What is Drugs Made In America Acquisition II Corp. Ordinary Shares's Market Cap?
Drugs Made In America Acquisition II Corp. Ordinary Shares's Market Cap is $649.1M, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · DMIIAs-filed SEC (XBRL) data
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025
Operating expenses
General and administrative costs
Total operating expenses——
Loss from operations
Other income
Interest earned on cash and investments held in Trust Account
Recovery of credit losses——
Total other income
Net income (loss)
Basic net income (loss) per ordinary share——
Diluted net income (loss) per ordinary share——